All consecutive patients admitted in ILBS from MAY 2015 to DECEMBER 2016. Decompensated cirrhosis patients will be randomized into Group 1: MVP (Moderate Volume Paracentesis) of less than 5 litres with iv albumin at a dose 8 gms/l of ascitic fluid Group 1: MVP (Moderate Volume Paracentesis) of less than 5 litres without albumin .
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
MVP of less than 5 liters with iv albumin at a dose 8 gms/L of ascitic fluid.
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Incidence of PICD (Paracentesis Induced Circulatory Dysfunction).
Time frame: 1 Year
Survival
Time frame: 28 days
Total number of patients develop Hepatorenal Syndrome.
Time frame: 1 Year
Total number of patients develop hyponatremia.
Time frame: 1 Year
Changes in plasma Renin activity.
Time frame: 1 Year
Changes in aldosterone with volume of ascitic fluid tap.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.